| Omar Elghawanmeh, MD | |
|
617 23rd St Ste 400, Ashland, KY 41101-2880 | |
| (606) 408-2820 | |
| (606) 326-0235 |
| Full Name | Omar Elghawanmeh |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 15 Years |
| Location | 617 23rd St Ste 400, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386873073 | NPI | - | NPPES |
| 7100423270 | Medicaid | KY | |
| 0173050 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults.
Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers with Quest Diagnostics, the world's leading provider of diagnostic information services. Under the agreement, Quest Diagnostics will have the rights to use the biomarkers for the future, potential development of a clinical lab-developed test to aid in the detection of breast cancer recurrence.
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.
› Verified 7 days ago
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults.
Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers with Quest Diagnostics, the world's leading provider of diagnostic information services. Under the agreement, Quest Diagnostics will have the rights to use the biomarkers for the future, potential development of a clinical lab-developed test to aid in the detection of breast cancer recurrence.
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Omar Elghawanmeh, MD Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 408-6200 | Omar Elghawanmeh, MD 617 23rd St Ste 400, Ashland, KY 41101-2880 Ph: (606) 408-2820 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults.
Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers with Quest Diagnostics, the world's leading provider of diagnostic information services. Under the agreement, Quest Diagnostics will have the rights to use the biomarkers for the future, potential development of a clinical lab-developed test to aid in the detection of breast cancer recurrence.
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.
Using the radiocarbon dating method and special proteins in the lens of the eye, researchers at the University of Copenhagen and Aarhus can now establish, with relatively high precision, when a person was born.
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.
› Verified 7 days ago
Mrs. Maya Devi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 | |
Dr. Kathryn Guggenheim, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 617 23rd St, Ashland, KY 41101 Phone: 606-326-0300 Fax: 606-326-0235 | |
Wilma Castro, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 617 23rd St, Suite 12, Ashland, KY 41101 Phone: 606-326-1557 Fax: 606-326-1570 | |
Tanya Catherine Warwick, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St Ste 400, Ashland, KY 41101 Phone: 606-408-2820 Fax: 606-326-0235 | |
Khan Matin, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Lansdowne Dr, Ashland, KY 41101 Phone: 606-324-3005 Fax: 606-329-1530 | |
Dr. Bal K Bansal, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 700 Saint Christopher Dr Ste 101, Ashland, KY 41101 Phone: 606-836-0604 | |
Brittany Leigh Richardson, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 063-864-6826 |